British drugmaker GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the company said on Thursday.
For latest updates on coronavirus outbreak, click here
The company added it was in talks with governments on backing for the programme, which would effectively allow the expansion of the scale of production of future successful vaccines for the disease caused by the novel coronavirus.
Deccan Herald News now on Telegram - Click here to subscribe
Follow us on Facebook | Twitter | Dailymotion | YouTube
Alicia Keys, Blake Lively give odes to NY at Met Gala
Johnny Depp was to have earned $22.5 mn for 'Pirates' 6
Hitler's 'Jewish' blood: An old conspiracy theory
DH Toon | Kishor's playing his cards close to his chest
Delhi airport overtakes Dubai as 2nd-busiest in March
Roads turn rivers as Bengaluru gets swamped by rain
Why your head hurts and how to deal with it
Vulnerabilities detected in Chrome, update browser now
Bengaluru woman offers man job on matrimonial site
Shore up soft skills and boost your career